Such a selective increase in csMUC16high ovarian cancer cells is supported by our observation that csMUC16pos-OVC that were resistant to NKL attack expressed a higher level of csMUC16 (Figure 9A). The gene discussed is GLIS2; the disease is ovarian carcinoma.